nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT2B7—Epirubicin—pancreatic cancer	0.109	0.175	CbGbCtD
Morphine—UGT1A1—Erlotinib—pancreatic cancer	0.101	0.163	CbGbCtD
Morphine—UGT1A1—Irinotecan—pancreatic cancer	0.0914	0.148	CbGbCtD
Morphine—CYP2C8—Tamoxifen—pancreatic cancer	0.0349	0.0563	CbGbCtD
Morphine—CYP2C8—Erlotinib—pancreatic cancer	0.0296	0.0479	CbGbCtD
Morphine—CYP2C8—Fluorouracil—pancreatic cancer	0.0257	0.0415	CbGbCtD
Morphine—ABCB1—Tamoxifen—pancreatic cancer	0.0236	0.0381	CbGbCtD
Morphine—CYP2D6—Tamoxifen—pancreatic cancer	0.0222	0.0359	CbGbCtD
Morphine—ABCB1—Gemcitabine—pancreatic cancer	0.0203	0.0328	CbGbCtD
Morphine—ABCB1—Erlotinib—pancreatic cancer	0.0201	0.0324	CbGbCtD
Morphine—CYP2D6—Erlotinib—pancreatic cancer	0.0189	0.0305	CbGbCtD
Morphine—ABCB1—Irinotecan—pancreatic cancer	0.0181	0.0293	CbGbCtD
Morphine—CYP3A4—Tamoxifen—pancreatic cancer	0.0141	0.0228	CbGbCtD
Morphine—ABCB1—Docetaxel—pancreatic cancer	0.0133	0.0214	CbGbCtD
Morphine—ABCB1—Sunitinib—pancreatic cancer	0.0132	0.0213	CbGbCtD
Morphine—CYP3A4—Erlotinib—pancreatic cancer	0.012	0.0194	CbGbCtD
Morphine—CYP3A4—Irinotecan—pancreatic cancer	0.0109	0.0175	CbGbCtD
Morphine—ABCB1—Doxorubicin—pancreatic cancer	0.0099	0.016	CbGbCtD
Morphine—CYP2D6—Doxorubicin—pancreatic cancer	0.00933	0.0151	CbGbCtD
Morphine—CYP3A4—Docetaxel—pancreatic cancer	0.00796	0.0128	CbGbCtD
Morphine—CYP3A4—Sunitinib—pancreatic cancer	0.00792	0.0128	CbGbCtD
Morphine—CYP3A4—Doxorubicin—pancreatic cancer	0.00593	0.00958	CbGbCtD
Morphine—UGT2B15—gall bladder—pancreatic cancer	0.003	0.241	CbGeAlD
Morphine—UGT2B15—islet of Langerhans—pancreatic cancer	0.00197	0.158	CbGeAlD
Morphine—UGT1A8—digestive system—pancreatic cancer	0.00141	0.113	CbGeAlD
Morphine—UGT2B15—pancreas—pancreatic cancer	0.00138	0.111	CbGeAlD
Morphine—UGT1A3—digestive system—pancreatic cancer	0.00126	0.101	CbGeAlD
Morphine—UGT2B15—digestive system—pancreatic cancer	0.00118	0.0948	CbGeAlD
Morphine—UGT2B7—digestive system—pancreatic cancer	0.000721	0.0579	CbGeAlD
Morphine—UGT1A1—digestive system—pancreatic cancer	0.000613	0.0492	CbGeAlD
Morphine—ABCB1—islet of Langerhans—pancreatic cancer	0.000232	0.0186	CbGeAlD
Morphine—CYP3A4—digestive system—pancreatic cancer	0.000196	0.0158	CbGeAlD
Morphine—CYP2D6—digestive system—pancreatic cancer	0.000193	0.0155	CbGeAlD
Morphine—ABCB1—pancreas—pancreatic cancer	0.000163	0.0131	CbGeAlD
Morphine—ABCB1—digestive system—pancreatic cancer	0.000139	0.0112	CbGeAlD
Morphine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000137	0.00057	CcSEcCtD
Morphine—Weight decreased—Epirubicin—pancreatic cancer	0.000137	0.000568	CcSEcCtD
Morphine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000136	0.000567	CcSEcCtD
Morphine—Cough—Docetaxel—pancreatic cancer	0.000136	0.000566	CcSEcCtD
Morphine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000136	0.000564	CcSEcCtD
Morphine—Convulsion—Docetaxel—pancreatic cancer	0.000135	0.000562	CcSEcCtD
Morphine—Hypertension—Docetaxel—pancreatic cancer	0.000135	0.00056	CcSEcCtD
Morphine—Drowsiness—Epirubicin—pancreatic cancer	0.000135	0.00056	CcSEcCtD
Morphine—Arthralgia—Docetaxel—pancreatic cancer	0.000133	0.000552	CcSEcCtD
Morphine—Chest pain—Docetaxel—pancreatic cancer	0.000133	0.000552	CcSEcCtD
Morphine—Nausea—Sunitinib—pancreatic cancer	0.000133	0.000552	CcSEcCtD
Morphine—Renal failure—Epirubicin—pancreatic cancer	0.000132	0.000551	CcSEcCtD
Morphine—Asthenia—Irinotecan—pancreatic cancer	0.000132	0.00055	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000132	0.000549	CcSEcCtD
Morphine—Stomatitis—Epirubicin—pancreatic cancer	0.000131	0.000546	CcSEcCtD
Morphine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000131	0.000544	CcSEcCtD
Morphine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000131	0.000544	CcSEcCtD
Morphine—Dysuria—Doxorubicin—pancreatic cancer	0.000131	0.000543	CcSEcCtD
Morphine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00013	0.000541	CcSEcCtD
Morphine—Dry mouth—Docetaxel—pancreatic cancer	0.00013	0.00054	CcSEcCtD
Morphine—Sweating—Epirubicin—pancreatic cancer	0.000129	0.000537	CcSEcCtD
Morphine—Asthenia—Gemcitabine—pancreatic cancer	0.000129	0.000535	CcSEcCtD
Morphine—Confusional state—Docetaxel—pancreatic cancer	0.000128	0.000534	CcSEcCtD
Morphine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000127	0.00053	CcSEcCtD
Morphine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000127	0.00053	CcSEcCtD
Morphine—Oedema—Docetaxel—pancreatic cancer	0.000127	0.00053	CcSEcCtD
Morphine—Pruritus—Gemcitabine—pancreatic cancer	0.000127	0.000528	CcSEcCtD
Morphine—Infection—Docetaxel—pancreatic cancer	0.000126	0.000526	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—pancreatic cancer	0.000126	0.000526	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000126	0.000524	CcSEcCtD
Morphine—Diarrhoea—Irinotecan—pancreatic cancer	0.000126	0.000524	CcSEcCtD
Morphine—Shock—Docetaxel—pancreatic cancer	0.000125	0.000521	CcSEcCtD
Morphine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000125	0.000519	CcSEcCtD
Morphine—Pruritus—Fluorouracil—pancreatic cancer	0.000125	0.000519	CcSEcCtD
Morphine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000125	0.000519	CcSEcCtD
Morphine—Drowsiness—Doxorubicin—pancreatic cancer	0.000125	0.000518	CcSEcCtD
Morphine—Tachycardia—Docetaxel—pancreatic cancer	0.000124	0.000517	CcSEcCtD
Morphine—Skin disorder—Docetaxel—pancreatic cancer	0.000124	0.000514	CcSEcCtD
Morphine—Bradycardia—Epirubicin—pancreatic cancer	0.000123	0.000512	CcSEcCtD
Morphine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000123	0.000511	CcSEcCtD
Morphine—Renal failure—Doxorubicin—pancreatic cancer	0.000122	0.000509	CcSEcCtD
Morphine—Dizziness—Irinotecan—pancreatic cancer	0.000122	0.000507	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—pancreatic cancer	0.000121	0.000505	CcSEcCtD
Morphine—Anorexia—Docetaxel—pancreatic cancer	0.000121	0.000505	CcSEcCtD
Morphine—Rhinitis—Epirubicin—pancreatic cancer	0.000121	0.000504	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000121	0.000504	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000121	0.000504	CcSEcCtD
Morphine—Hepatitis—Epirubicin—pancreatic cancer	0.000121	0.000503	CcSEcCtD
Morphine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000121	0.000502	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00012	0.0005	CcSEcCtD
Morphine—Sweating—Doxorubicin—pancreatic cancer	0.000119	0.000497	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000119	0.000497	CcSEcCtD
Morphine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000119	0.000495	CcSEcCtD
Morphine—Hypotension—Docetaxel—pancreatic cancer	0.000119	0.000495	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000119	0.000494	CcSEcCtD
Morphine—Urethral disorder—Epirubicin—pancreatic cancer	0.000118	0.000493	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000118	0.00049	CcSEcCtD
Morphine—Vomiting—Irinotecan—pancreatic cancer	0.000117	0.000487	CcSEcCtD
Morphine—Dizziness—Fluorouracil—pancreatic cancer	0.000117	0.000485	CcSEcCtD
Morphine—Visual impairment—Epirubicin—pancreatic cancer	0.000116	0.000485	CcSEcCtD
Morphine—Rash—Irinotecan—pancreatic cancer	0.000116	0.000483	CcSEcCtD
Morphine—Dermatitis—Irinotecan—pancreatic cancer	0.000116	0.000483	CcSEcCtD
Morphine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000116	0.000482	CcSEcCtD
Morphine—Headache—Irinotecan—pancreatic cancer	0.000115	0.00048	CcSEcCtD
Morphine—Insomnia—Docetaxel—pancreatic cancer	0.000115	0.000479	CcSEcCtD
Morphine—Paraesthesia—Docetaxel—pancreatic cancer	0.000114	0.000476	CcSEcCtD
Morphine—Vomiting—Gemcitabine—pancreatic cancer	0.000114	0.000474	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—pancreatic cancer	0.000114	0.000474	CcSEcCtD
Morphine—Dyspnoea—Docetaxel—pancreatic cancer	0.000113	0.000472	CcSEcCtD
Morphine—Somnolence—Docetaxel—pancreatic cancer	0.000113	0.000471	CcSEcCtD
Morphine—Rash—Gemcitabine—pancreatic cancer	0.000113	0.000471	CcSEcCtD
Morphine—Dermatitis—Gemcitabine—pancreatic cancer	0.000113	0.00047	CcSEcCtD
Morphine—Eye disorder—Epirubicin—pancreatic cancer	0.000113	0.00047	CcSEcCtD
Morphine—Headache—Gemcitabine—pancreatic cancer	0.000112	0.000467	CcSEcCtD
Morphine—Flushing—Epirubicin—pancreatic cancer	0.000112	0.000467	CcSEcCtD
Morphine—Vomiting—Fluorouracil—pancreatic cancer	0.000112	0.000467	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—pancreatic cancer	0.000112	0.000466	CcSEcCtD
Morphine—Dyspepsia—Docetaxel—pancreatic cancer	0.000112	0.000466	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—pancreatic cancer	0.000112	0.000465	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000111	0.000463	CcSEcCtD
Morphine—Rash—Fluorouracil—pancreatic cancer	0.000111	0.000463	CcSEcCtD
Morphine—Dermatitis—Fluorouracil—pancreatic cancer	0.000111	0.000462	CcSEcCtD
Morphine—Decreased appetite—Docetaxel—pancreatic cancer	0.000111	0.00046	CcSEcCtD
Morphine—Headache—Fluorouracil—pancreatic cancer	0.00011	0.00046	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.00011	0.000459	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00011	0.000458	CcSEcCtD
Morphine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00011	0.000457	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00011	0.000457	CcSEcCtD
Morphine—Fatigue—Docetaxel—pancreatic cancer	0.00011	0.000457	CcSEcCtD
Morphine—Angiopathy—Epirubicin—pancreatic cancer	0.00011	0.000456	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—pancreatic cancer	0.00011	0.000456	CcSEcCtD
Morphine—Nausea—Irinotecan—pancreatic cancer	0.000109	0.000455	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000109	0.000453	CcSEcCtD
Morphine—Pain—Docetaxel—pancreatic cancer	0.000109	0.000453	CcSEcCtD
Morphine—Constipation—Docetaxel—pancreatic cancer	0.000109	0.000453	CcSEcCtD
Morphine—Chills—Epirubicin—pancreatic cancer	0.000108	0.000451	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—pancreatic cancer	0.000108	0.000448	CcSEcCtD
Morphine—Nausea—Gemcitabine—pancreatic cancer	0.000107	0.000443	CcSEcCtD
Morphine—Mental disorder—Epirubicin—pancreatic cancer	0.000106	0.00044	CcSEcCtD
Morphine—Erythema—Epirubicin—pancreatic cancer	0.000105	0.000438	CcSEcCtD
Morphine—Malnutrition—Epirubicin—pancreatic cancer	0.000105	0.000438	CcSEcCtD
Morphine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000105	0.000436	CcSEcCtD
Morphine—Nausea—Fluorouracil—pancreatic cancer	0.000105	0.000436	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—pancreatic cancer	0.000104	0.000435	CcSEcCtD
Morphine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000104	0.000433	CcSEcCtD
Morphine—Flushing—Doxorubicin—pancreatic cancer	0.000104	0.000432	CcSEcCtD
Morphine—Flatulence—Epirubicin—pancreatic cancer	0.000104	0.000431	CcSEcCtD
Morphine—Tension—Epirubicin—pancreatic cancer	0.000103	0.000429	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—pancreatic cancer	0.000103	0.000429	CcSEcCtD
Morphine—Nervousness—Epirubicin—pancreatic cancer	0.000102	0.000425	CcSEcCtD
Morphine—Back pain—Epirubicin—pancreatic cancer	0.000102	0.000423	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—pancreatic cancer	0.000101	0.000422	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—pancreatic cancer	0.000101	0.000421	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000101	0.000419	CcSEcCtD
Morphine—Abdominal pain—Docetaxel—pancreatic cancer	0.000101	0.000419	CcSEcCtD
Morphine—Body temperature increased—Docetaxel—pancreatic cancer	0.000101	0.000419	CcSEcCtD
Morphine—Chills—Doxorubicin—pancreatic cancer	0.0001	0.000417	CcSEcCtD
Morphine—Vision blurred—Epirubicin—pancreatic cancer	9.91e-05	0.000412	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—pancreatic cancer	9.79e-05	0.000408	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—pancreatic cancer	9.76e-05	0.000406	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—pancreatic cancer	9.73e-05	0.000405	CcSEcCtD
Morphine—Erythema—Doxorubicin—pancreatic cancer	9.73e-05	0.000405	CcSEcCtD
Morphine—Anaemia—Epirubicin—pancreatic cancer	9.72e-05	0.000405	CcSEcCtD
Morphine—Agitation—Epirubicin—pancreatic cancer	9.67e-05	0.000402	CcSEcCtD
Morphine—Flatulence—Doxorubicin—pancreatic cancer	9.59e-05	0.000399	CcSEcCtD
Morphine—Tension—Doxorubicin—pancreatic cancer	9.55e-05	0.000397	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—pancreatic cancer	9.53e-05	0.000397	CcSEcCtD
Morphine—Malaise—Epirubicin—pancreatic cancer	9.49e-05	0.000395	CcSEcCtD
Morphine—Nervousness—Doxorubicin—pancreatic cancer	9.45e-05	0.000393	CcSEcCtD
Morphine—Vertigo—Epirubicin—pancreatic cancer	9.45e-05	0.000393	CcSEcCtD
Morphine—Syncope—Epirubicin—pancreatic cancer	9.43e-05	0.000392	CcSEcCtD
Morphine—Leukopenia—Epirubicin—pancreatic cancer	9.42e-05	0.000392	CcSEcCtD
Morphine—Back pain—Doxorubicin—pancreatic cancer	9.41e-05	0.000392	CcSEcCtD
Morphine—Hypersensitivity—Docetaxel—pancreatic cancer	9.38e-05	0.00039	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—pancreatic cancer	9.36e-05	0.000389	CcSEcCtD
Morphine—Palpitations—Epirubicin—pancreatic cancer	9.3e-05	0.000387	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—pancreatic cancer	9.24e-05	0.000385	CcSEcCtD
Morphine—Cough—Epirubicin—pancreatic cancer	9.18e-05	0.000382	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—pancreatic cancer	9.17e-05	0.000382	CcSEcCtD
Morphine—Asthenia—Docetaxel—pancreatic cancer	9.13e-05	0.00038	CcSEcCtD
Morphine—Convulsion—Epirubicin—pancreatic cancer	9.11e-05	0.000379	CcSEcCtD
Morphine—Hypertension—Epirubicin—pancreatic cancer	9.08e-05	0.000378	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.03e-05	0.000376	CcSEcCtD
Morphine—Pruritus—Docetaxel—pancreatic cancer	9e-05	0.000375	CcSEcCtD
Morphine—Anaemia—Doxorubicin—pancreatic cancer	9e-05	0.000374	CcSEcCtD
Morphine—Chest pain—Epirubicin—pancreatic cancer	8.95e-05	0.000373	CcSEcCtD
Morphine—Arthralgia—Epirubicin—pancreatic cancer	8.95e-05	0.000373	CcSEcCtD
Morphine—Agitation—Doxorubicin—pancreatic cancer	8.94e-05	0.000372	CcSEcCtD
Morphine—Anxiety—Epirubicin—pancreatic cancer	8.92e-05	0.000371	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.89e-05	0.00037	CcSEcCtD
Morphine—Discomfort—Epirubicin—pancreatic cancer	8.85e-05	0.000368	CcSEcCtD
Morphine—Malaise—Doxorubicin—pancreatic cancer	8.78e-05	0.000365	CcSEcCtD
Morphine—Dry mouth—Epirubicin—pancreatic cancer	8.76e-05	0.000364	CcSEcCtD
Morphine—Vertigo—Doxorubicin—pancreatic cancer	8.74e-05	0.000364	CcSEcCtD
Morphine—Syncope—Doxorubicin—pancreatic cancer	8.73e-05	0.000363	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—pancreatic cancer	8.71e-05	0.000362	CcSEcCtD
Morphine—Diarrhoea—Docetaxel—pancreatic cancer	8.71e-05	0.000362	CcSEcCtD
Morphine—Confusional state—Epirubicin—pancreatic cancer	8.66e-05	0.00036	CcSEcCtD
Morphine—Palpitations—Doxorubicin—pancreatic cancer	8.6e-05	0.000358	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—pancreatic cancer	8.58e-05	0.000357	CcSEcCtD
Morphine—Oedema—Epirubicin—pancreatic cancer	8.58e-05	0.000357	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—pancreatic cancer	8.55e-05	0.000356	CcSEcCtD
Morphine—Infection—Epirubicin—pancreatic cancer	8.53e-05	0.000355	CcSEcCtD
Morphine—Cough—Doxorubicin—pancreatic cancer	8.49e-05	0.000353	CcSEcCtD
Morphine—Shock—Epirubicin—pancreatic cancer	8.45e-05	0.000351	CcSEcCtD
Morphine—Convulsion—Doxorubicin—pancreatic cancer	8.43e-05	0.000351	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—pancreatic cancer	8.42e-05	0.00035	CcSEcCtD
Morphine—Dizziness—Docetaxel—pancreatic cancer	8.42e-05	0.00035	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—pancreatic cancer	8.4e-05	0.00035	CcSEcCtD
Morphine—Hypertension—Doxorubicin—pancreatic cancer	8.4e-05	0.00035	CcSEcCtD
Morphine—Tachycardia—Epirubicin—pancreatic cancer	8.38e-05	0.000349	CcSEcCtD
Morphine—Skin disorder—Epirubicin—pancreatic cancer	8.34e-05	0.000347	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—pancreatic cancer	8.3e-05	0.000345	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—pancreatic cancer	8.29e-05	0.000345	CcSEcCtD
Morphine—Chest pain—Doxorubicin—pancreatic cancer	8.29e-05	0.000345	CcSEcCtD
Morphine—Anxiety—Doxorubicin—pancreatic cancer	8.26e-05	0.000344	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.23e-05	0.000342	CcSEcCtD
Morphine—Discomfort—Doxorubicin—pancreatic cancer	8.19e-05	0.000341	CcSEcCtD
Morphine—Anorexia—Epirubicin—pancreatic cancer	8.18e-05	0.00034	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—pancreatic cancer	8.1e-05	0.000337	CcSEcCtD
Morphine—Vomiting—Docetaxel—pancreatic cancer	8.09e-05	0.000337	CcSEcCtD
Morphine—Rash—Docetaxel—pancreatic cancer	8.02e-05	0.000334	CcSEcCtD
Morphine—Hypotension—Epirubicin—pancreatic cancer	8.02e-05	0.000334	CcSEcCtD
Morphine—Dermatitis—Docetaxel—pancreatic cancer	8.02e-05	0.000334	CcSEcCtD
Morphine—Confusional state—Doxorubicin—pancreatic cancer	8.01e-05	0.000333	CcSEcCtD
Morphine—Headache—Docetaxel—pancreatic cancer	7.97e-05	0.000332	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.94e-05	0.000331	CcSEcCtD
Morphine—Oedema—Doxorubicin—pancreatic cancer	7.94e-05	0.000331	CcSEcCtD
Morphine—Infection—Doxorubicin—pancreatic cancer	7.89e-05	0.000328	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.82e-05	0.000325	CcSEcCtD
Morphine—Shock—Doxorubicin—pancreatic cancer	7.81e-05	0.000325	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—pancreatic cancer	7.79e-05	0.000324	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.78e-05	0.000324	CcSEcCtD
Morphine—Insomnia—Epirubicin—pancreatic cancer	7.76e-05	0.000323	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—pancreatic cancer	7.75e-05	0.000323	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—pancreatic cancer	7.72e-05	0.000321	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—pancreatic cancer	7.71e-05	0.000321	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.68e-05	0.00032	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—pancreatic cancer	7.65e-05	0.000318	CcSEcCtD
Morphine—Somnolence—Epirubicin—pancreatic cancer	7.63e-05	0.000318	CcSEcCtD
Morphine—Anorexia—Doxorubicin—pancreatic cancer	7.57e-05	0.000315	CcSEcCtD
Morphine—Nausea—Docetaxel—pancreatic cancer	7.56e-05	0.000315	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—pancreatic cancer	7.56e-05	0.000314	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—pancreatic cancer	7.46e-05	0.000311	CcSEcCtD
Morphine—Hypotension—Doxorubicin—pancreatic cancer	7.42e-05	0.000309	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.41e-05	0.000308	CcSEcCtD
Morphine—Fatigue—Epirubicin—pancreatic cancer	7.4e-05	0.000308	CcSEcCtD
Morphine—Constipation—Epirubicin—pancreatic cancer	7.34e-05	0.000305	CcSEcCtD
Morphine—Pain—Epirubicin—pancreatic cancer	7.34e-05	0.000305	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.24e-05	0.000301	CcSEcCtD
Morphine—Insomnia—Doxorubicin—pancreatic cancer	7.18e-05	0.000299	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—pancreatic cancer	7.13e-05	0.000297	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—pancreatic cancer	7.08e-05	0.000295	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—pancreatic cancer	7.07e-05	0.000294	CcSEcCtD
Morphine—Somnolence—Doxorubicin—pancreatic cancer	7.06e-05	0.000294	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.02e-05	0.000292	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—pancreatic cancer	6.99e-05	0.000291	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—pancreatic cancer	6.9e-05	0.000287	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.86e-05	0.000285	CcSEcCtD
Morphine—Fatigue—Doxorubicin—pancreatic cancer	6.85e-05	0.000285	CcSEcCtD
Morphine—Urticaria—Epirubicin—pancreatic cancer	6.82e-05	0.000284	CcSEcCtD
Morphine—Constipation—Doxorubicin—pancreatic cancer	6.79e-05	0.000283	CcSEcCtD
Morphine—Pain—Doxorubicin—pancreatic cancer	6.79e-05	0.000283	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—pancreatic cancer	6.79e-05	0.000282	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—pancreatic cancer	6.79e-05	0.000282	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—pancreatic cancer	6.55e-05	0.000272	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.5e-05	0.00027	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—pancreatic cancer	6.32e-05	0.000263	CcSEcCtD
Morphine—Urticaria—Doxorubicin—pancreatic cancer	6.31e-05	0.000263	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—pancreatic cancer	6.28e-05	0.000261	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—pancreatic cancer	6.28e-05	0.000261	CcSEcCtD
Morphine—Asthenia—Epirubicin—pancreatic cancer	6.16e-05	0.000256	CcSEcCtD
Morphine—Pruritus—Epirubicin—pancreatic cancer	6.07e-05	0.000253	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—pancreatic cancer	5.87e-05	0.000244	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—pancreatic cancer	5.85e-05	0.000244	CcSEcCtD
Morphine—Asthenia—Doxorubicin—pancreatic cancer	5.7e-05	0.000237	CcSEcCtD
Morphine—Dizziness—Epirubicin—pancreatic cancer	5.68e-05	0.000236	CcSEcCtD
Morphine—Pruritus—Doxorubicin—pancreatic cancer	5.62e-05	0.000234	CcSEcCtD
Morphine—Vomiting—Epirubicin—pancreatic cancer	5.46e-05	0.000227	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—pancreatic cancer	5.43e-05	0.000226	CcSEcCtD
Morphine—Rash—Epirubicin—pancreatic cancer	5.41e-05	0.000225	CcSEcCtD
Morphine—Dermatitis—Epirubicin—pancreatic cancer	5.41e-05	0.000225	CcSEcCtD
Morphine—Headache—Epirubicin—pancreatic cancer	5.38e-05	0.000224	CcSEcCtD
Morphine—Dizziness—Doxorubicin—pancreatic cancer	5.25e-05	0.000219	CcSEcCtD
Morphine—Nausea—Epirubicin—pancreatic cancer	5.1e-05	0.000212	CcSEcCtD
Morphine—Vomiting—Doxorubicin—pancreatic cancer	5.05e-05	0.00021	CcSEcCtD
Morphine—Rash—Doxorubicin—pancreatic cancer	5.01e-05	0.000208	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—pancreatic cancer	5e-05	0.000208	CcSEcCtD
Morphine—Headache—Doxorubicin—pancreatic cancer	4.98e-05	0.000207	CcSEcCtD
Morphine—Nausea—Doxorubicin—pancreatic cancer	4.72e-05	0.000196	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	1.98e-05	0.000154	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMP—pancreatic cancer	1.98e-05	0.000154	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.97e-05	0.000154	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GCG—pancreatic cancer	1.97e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	1.96e-05	0.000153	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—APOE—pancreatic cancer	1.95e-05	0.000152	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TYMS—pancreatic cancer	1.95e-05	0.000152	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.94e-05	0.000151	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.93e-05	0.000151	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	1.92e-05	0.00015	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.91e-05	0.000149	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.9e-05	0.000148	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.9e-05	0.000148	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—pancreatic cancer	1.88e-05	0.000147	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	1.88e-05	0.000147	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HES1—pancreatic cancer	1.87e-05	0.000146	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.87e-05	0.000146	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TERT—pancreatic cancer	1.87e-05	0.000146	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.86e-05	0.000145	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STK11—pancreatic cancer	1.85e-05	0.000144	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GLP1R—pancreatic cancer	1.83e-05	0.000143	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CD—pancreatic cancer	1.82e-05	0.000142	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.81e-05	0.000141	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—pancreatic cancer	1.8e-05	0.000141	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—pancreatic cancer	1.8e-05	0.000141	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—DPYD—pancreatic cancer	1.8e-05	0.00014	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.79e-05	0.00014	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.79e-05	0.00014	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	1.79e-05	0.00014	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	1.78e-05	0.000139	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	1.76e-05	0.000137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—APOE—pancreatic cancer	1.75e-05	0.000136	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	1.74e-05	0.000136	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—pancreatic cancer	1.72e-05	0.000135	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	1.72e-05	0.000135	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KDR—pancreatic cancer	1.71e-05	0.000134	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	1.71e-05	0.000133	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARG—pancreatic cancer	1.7e-05	0.000133	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.69e-05	0.000132	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—pancreatic cancer	1.68e-05	0.000132	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—pancreatic cancer	1.67e-05	0.00013	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.67e-05	0.00013	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.65e-05	0.000129	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TERT—pancreatic cancer	1.64e-05	0.000128	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.63e-05	0.000127	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	1.63e-05	0.000127	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	1.62e-05	0.000127	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	1.61e-05	0.000126	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.61e-05	0.000125	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	1.6e-05	0.000125	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—pancreatic cancer	1.6e-05	0.000125	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.59e-05	0.000124	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.59e-05	0.000124	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	1.58e-05	0.000124	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—APOE—pancreatic cancer	1.58e-05	0.000124	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HES1—pancreatic cancer	1.58e-05	0.000124	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	1.58e-05	0.000123	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	1.58e-05	0.000123	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—pancreatic cancer	1.57e-05	0.000123	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	1.57e-05	0.000123	CbGpPWpGaD
Morphine—ABCB1—Metabolism—DPYD—pancreatic cancer	1.57e-05	0.000122	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	1.56e-05	0.000122	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGF—pancreatic cancer	1.56e-05	0.000122	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	1.54e-05	0.000121	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—APOE—pancreatic cancer	1.53e-05	0.00012	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	1.51e-05	0.000118	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.5e-05	0.000117	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KDR—pancreatic cancer	1.5e-05	0.000117	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.49e-05	0.000116	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.48e-05	0.000116	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.48e-05	0.000115	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—pancreatic cancer	1.47e-05	0.000115	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—pancreatic cancer	1.47e-05	0.000115	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	1.46e-05	0.000114	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	1.44e-05	0.000112	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	1.43e-05	0.000112	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	1.43e-05	0.000111	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	1.41e-05	0.00011	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—pancreatic cancer	1.41e-05	0.00011	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.4e-05	0.000109	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.39e-05	0.000109	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TERT—pancreatic cancer	1.39e-05	0.000108	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	1.39e-05	0.000108	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	1.38e-05	0.000108	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	1.38e-05	0.000108	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—pancreatic cancer	1.38e-05	0.000108	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.37e-05	0.000107	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—pancreatic cancer	1.37e-05	0.000107	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGF—pancreatic cancer	1.37e-05	0.000107	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	1.36e-05	0.000106	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	1.35e-05	0.000105	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.34e-05	0.000105	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—pancreatic cancer	1.33e-05	0.000104	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	1.33e-05	0.000104	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	1.32e-05	0.000103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CD44—pancreatic cancer	1.32e-05	0.000103	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—APOE—pancreatic cancer	1.29e-05	0.000101	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.29e-05	0.000101	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.28e-05	0.0001	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KDR—pancreatic cancer	1.27e-05	9.9e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GCG—pancreatic cancer	1.27e-05	9.9e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	1.26e-05	9.83e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	1.26e-05	9.81e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.25e-05	9.73e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.22e-05	9.51e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	1.21e-05	9.49e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.21e-05	9.43e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.21e-05	9.42e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.2e-05	9.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.19e-05	9.33e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—STK11—pancreatic cancer	1.19e-05	9.3e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	1.19e-05	9.29e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.17e-05	9.12e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.17e-05	9.12e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—pancreatic cancer	1.16e-05	9.09e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.16e-05	9.06e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGF—pancreatic cancer	1.15e-05	9.02e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.15e-05	9.01e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CD44—pancreatic cancer	1.15e-05	8.99e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.12e-05	8.76e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.12e-05	8.73e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	1.11e-05	8.68e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GCG—pancreatic cancer	1.1e-05	8.62e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	1.09e-05	8.55e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.09e-05	8.53e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.08e-05	8.47e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—pancreatic cancer	1.08e-05	8.47e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	1.08e-05	8.44e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.07e-05	8.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.06e-05	8.31e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.06e-05	8.27e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	1.05e-05	8.2e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	1.04e-05	8.15e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.04e-05	8.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—STK11—pancreatic cancer	1.04e-05	8.11e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.03e-05	8.02e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.02e-05	8e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.02e-05	7.95e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.02e-05	7.95e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.02e-05	7.94e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.01e-05	7.9e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1e-05	7.85e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	9.83e-06	7.68e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.81e-06	7.66e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—STK11—pancreatic cancer	9.78e-06	7.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	9.74e-06	7.61e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—pancreatic cancer	9.67e-06	7.56e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	9.65e-06	7.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.65e-06	7.54e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	9.48e-06	7.4e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—pancreatic cancer	9.46e-06	7.39e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	9.42e-06	7.36e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	9.39e-06	7.33e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	9.33e-06	7.29e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	9.31e-06	7.27e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.23e-06	7.21e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	9.2e-06	7.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	9.16e-06	7.15e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	9.15e-06	7.15e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	8.95e-06	6.99e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—pancreatic cancer	8.93e-06	6.97e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	8.92e-06	6.97e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—pancreatic cancer	8.67e-06	6.77e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	8.65e-06	6.76e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	8.6e-06	6.72e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	8.54e-06	6.67e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—pancreatic cancer	8.48e-06	6.63e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	8.48e-06	6.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—pancreatic cancer	8.41e-06	6.57e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—APOE—pancreatic cancer	8.33e-06	6.51e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	8.31e-06	6.49e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	8.26e-06	6.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	8.23e-06	6.43e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	8.21e-06	6.41e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	8.18e-06	6.39e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	8.16e-06	6.38e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	8.01e-06	6.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	8.01e-06	6.26e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	7.93e-06	6.2e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.89e-06	6.16e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—pancreatic cancer	7.89e-06	6.16e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	7.78e-06	6.08e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	7.73e-06	6.04e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—pancreatic cancer	7.6e-06	5.94e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	7.58e-06	5.92e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	7.54e-06	5.89e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	7.52e-06	5.87e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	7.44e-06	5.81e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	7.36e-06	5.75e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—APOE—pancreatic cancer	7.26e-06	5.67e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—pancreatic cancer	7.26e-06	5.67e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—pancreatic cancer	7.17e-06	5.6e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—pancreatic cancer	7.12e-06	5.56e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CD44—pancreatic cancer	7.09e-06	5.54e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	7.02e-06	5.49e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	6.98e-06	5.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	6.91e-06	5.4e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	6.9e-06	5.39e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—APOE—pancreatic cancer	6.84e-06	5.34e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	6.81e-06	5.32e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GCG—pancreatic cancer	6.8e-06	5.31e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—pancreatic cancer	6.71e-06	5.24e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	6.67e-06	5.21e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	6.61e-06	5.16e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.55e-06	5.12e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	6.45e-06	5.04e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—pancreatic cancer	6.42e-06	5.02e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	6.41e-06	5.01e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—STK11—pancreatic cancer	6.39e-06	4.99e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—pancreatic cancer	6.32e-06	4.94e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	6.28e-06	4.91e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—pancreatic cancer	6.24e-06	4.88e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	6.17e-06	4.82e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	6.01e-06	4.7e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	5.97e-06	4.66e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.96e-06	4.65e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	5.94e-06	4.64e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	5.76e-06	4.5e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.76e-06	4.5e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	5.71e-06	4.46e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.5e-06	4.3e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	5.45e-06	4.26e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—pancreatic cancer	5.45e-06	4.26e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.43e-06	4.24e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—pancreatic cancer	5.28e-06	4.12e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	5.27e-06	4.12e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	5.05e-06	3.94e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.02e-06	3.92e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—pancreatic cancer	4.98e-06	3.89e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.97e-06	3.89e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.73e-06	3.7e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.69e-06	3.66e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—APOE—pancreatic cancer	4.47e-06	3.49e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	4.46e-06	3.48e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—pancreatic cancer	4.34e-06	3.39e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.09e-06	3.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.04e-06	3.15e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.9e-06	3.04e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.55e-06	2.77e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	3.51e-06	2.74e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.09e-06	2.42e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.06e-06	2.39e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.06e-06	2.39e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.88e-06	2.25e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—pancreatic cancer	2.87e-06	2.24e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.67e-06	2.09e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—pancreatic cancer	2.5e-06	1.95e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.36e-06	1.84e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.89e-06	1.47e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.54e-06	1.2e-05	CbGpPWpGaD
